EDIT
Editas Medicine Inc
2.80$
+6.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 71.1% | 68.3% | 69.4% | 74.4% | 82.8% | 84.7% | 85.3% | 86.8% | 87.7% | 87.9% | 85.8% | 91.9% | |
| 16.4% | 24.8% | 15.7% | 16.7% | 29.3% | 38.5% | 52.6% | 65.8% | 82.1% | 78.6% | 82.8% | 76.6% | |
| 69.3% | 64.7% | 67.3% | 72.5% | 80.9% | 79.0% | 83.8% | 84.8% | 82.1% | 78.6% | 82.8% | 89.2% | |
| 0.5% | 2.0% | 0.1% | 0.1% | 0.0% | 4.8% | 0.2% | 0.3% | 4.0% | 8.1% | 1.7% | 1.1% | |
| -1.8% | – | – | 0.0% | – | – | – | – | – | – | – | – | |
| 8.6% | – | – | – | – | – | – | – | – | – | – | – | |
| 28.6% | 30.1% | 33.1% | 39.7% | 46.4% | 60.7% | 76.3% | 90.9% | 93.3% | 85.4% | 97.0% | 55.6% | |
| 11.6% | 12.7% | 15.1% | 19.3% | 22.1% | 22.6% | 27.7% | 31.3% | 30.6% | 24.8% | 26.6% | 28.8% | |
| 1.9% | 4.8% | 2.8% | 4.7% | 5.0% | 4.3% | 5.0% | 2.9% | 3.0% | 5.9% | 9.5% | 2.7% | |
| 2.1% | 1.7% | 1.8% | 3.6% | 3.8% | 1.6% | 2.1% | 3.2% | 1.6% | 1.4% | 2.9% | 2.0% | |
| 71.4% | 69.9% | 66.9% | 60.3% | 53.6% | 39.3% | 23.7% | 9.1% | 6.7% | 14.6% | 3.0% | 44.4% | |
| -240.3% | -246.7% | -293.7% | -353.7% | -434.4% | -429.9% | -585.8% | -758.7% | -804.4% | -873.0% | -1,107.2% | -704.3% | |
| 16.2% | 16.4% | 18.6% | 21.4% | 25.2% | 24.2% | 31.5% | 40.1% | 44.7% | 47.6% | 65.5% | 50.3% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.